Lv7
4928 积分 2021-11-03 加入
Abstract 6271: Discovery of BR1733 for the treatment of SWI/SNF deficient or highly vascularized solid tumor
3天前
求助中
Abstract 452: ORIC-944, a PRC2 inhibitor with best-in-class properties, restores luminal features and restricts adaptation in prostate cancer models, conferring synergy with AR pathway inhibitors
3天前
求助中
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study
1个月前
已完结
Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic sensitivity analyses in patients with chronic myeloid leukemia
4个月前
已完结
Preclinical characterization of TGRX-678, a brain-penetrant allosteric inhibitor of BCR::ABL1
4个月前
已关闭
Tgrx-678, a Novel Allosteric Inhibitor of BCR-ABL1, Demonstrates Preclinical Anti-Leukemia Activity, High Oral Bioavailability and Synergism with Ponatinib to Suppress the Highly Resistant Compound Mutations
4个月前
已关闭
Preclinical characterization of TGRX-678, a brain-penetrant allosteric inhibitor of BCR::ABL1
4个月前
已完结
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
5个月前
已完结
[Lung resection for lung cancer patients on hemodialysis]
5个月前
已关闭
[Cardiac surgery in hemodialysis patients]
5个月前
已关闭
皖公网安备34019202002308
